Miller Aine has filed 12 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 16851 shares of Theravance Biopharma, Inc. ($TBPH) on February 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 16851 | $19.66 | 184,161.0000 | 51,908,000 | 8.38% | 0.03% |
| Nov. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 6989 | $17.90 | 201,012.0000 | 51,908,000 | 3.36% | 0.01% |
| Aug. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 6989 | $13.39 | 208,001.0000 | 50,726,000 | 3.25% | 0.01% |
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | A | Ordinary Shares | 10430 | $0.00 | 224,691.0000 | 49,706,000 | 4.87% | 0.02% |
| May 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 9701 | $9.45 | 214,990.0000 | 49,706,000 | 4.32% | 0.02% |
| Feb. 28, 2025 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | A | Ordinary Shares | 75000 | $0.00 | 214,261.0000 | 48,847,000 | 53.86% | 0.15% |
| Feb. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 11295 | $9.66 | 139,261.0000 | 48,847,000 | 7.50% | 0.02% |
| Nov. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 10076 | $9.97 | 150,556.0000 | 49,038,000 | 6.27% | 0.02% |
| Aug. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 5201 | $8.22 | 160,632.0000 | 48,747,000 | 3.14% | 0.01% |
| May 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 5201 | $9.10 | 165,833.0000 | 48,283,000 | 3.04% | 0.01% |
| April 2, 2024 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | A | Ordinary Shares | 37500 | $0.00 | 171,034.0000 | 48,283,000 | 28.08% | 0.08% |
| Feb. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F | Ordinary Shares | 11782 | $8.92 | 133,534.0000 | 55,303,000 | 8.11% | 0.02% |